Advertisement

Reactions Weekly

, Volume 1781, Issue 1, pp 341–341 | Cite as

Vedolizumab

Cholangiocarcinoma and colorectal neoplasia: 9 case reports
Case report
  • 17 Downloads

Reference

  1. Caron B, et al. Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study. Journal of Crohn's and Colitis 13: 1239-1247, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1093/ecco-jcc/jjz088 - FranceCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations